Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

RAISE - rheumatoid arthritis independent Swiss treatment expectations and outcome: results for the abatacept subpopulation.

Dudler J, Tuerk R, Handschin T, Forster A.

Swiss Med Wkly. 2013 Dec 6;143:w13849. doi: 10.4414/smw.2013.13849.

2.

Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study.

Nüßlein HG, Alten R, Galeazzi M, Lorenz HM, Boumpas D, Nurmohamed MT, Bensen WG, Burmester GR, Peter HH, Rainer F, Pavelka K, Chartier M, Poncet C, Rauch C, Bars ML.

BMC Musculoskelet Disord. 2014 Jan 11;15:14. doi: 10.1186/1471-2474-15-14.

3.

Biologic-free remission of established rheumatoid arthritis after discontinuation of abatacept: a prospective, multicentre, observational study in Japan.

Takeuchi T, Matsubara T, Ohta S, Mukai M, Amano K, Tohma S, Tanaka Y, Yamanaka H, Miyasaka N.

Rheumatology (Oxford). 2015 Apr;54(4):683-91. doi: 10.1093/rheumatology/keu338.

4.

Indirect treatment comparison of abatacept with methotrexate versus other biologic agents for active rheumatoid arthritis despite methotrexate therapy in the United kingdom.

Guyot P, Taylor PC, Christensen R, Pericleous L, Drost P, Eijgelshoven I, Bergman G, Lebmeier M.

J Rheumatol. 2012 Jun;39(6):1198-206. doi: 10.3899/jrheum.111345. Review.

PMID:
22505698
5.

Evaluation of abatacept in biologic-naïve patients with active rheumatoid arthritis.

Schiff M, Bessette L.

Clin Rheumatol. 2010 Jun;29(6):583-91. doi: 10.1007/s10067-009-1363-0. Review.

PMID:
20099018
6.

Abatacept with methotrexate versus other biologic agents in treatment of patients with active rheumatoid arthritis despite methotrexate: a network meta-analysis.

Guyot P, Taylor P, Christensen R, Pericleous L, Poncet C, Lebmeier M, Drost P, Bergman G.

Arthritis Res Ther. 2011;13(6):R204. doi: 10.1186/ar3537. Review.

8.

Clinical efficacy of abatacept in Japanese rheumatoid arthritis patients.

Takahashi N, Kojima T, Terabe K, Kaneko A, Kida D, Hirano Y, Fujibayashi T, Yabe Y, Takagi H, Oguchi T, Miyake H, Kato T, Fukaya N, Ishikawa H, Hayashi M, Tsuboi S, Kato D, Funahashi K, Matsubara H, Hattori Y, Hanabayashi M, Hirabara S, Yoshioka Y, Ishiguro N.

Mod Rheumatol. 2013 Sep;23(5):904-12. doi: 10.1007/s10165-012-0760-4.

PMID:
22975734
9.

Clinical and patient-reported outcomes in clinical trials of abatacept in the treatment of rheumatoid arthritis.

Massarotti EM.

Clin Ther. 2008 Mar;30(3):429-42. doi: 10.1016/j.clinthera.2008.03.002. Review.

PMID:
18405783
10.

Safety profile of abatacept in rheumatoid arthritis: a review.

Khraishi M, Russell A, Olszynski WP.

Clin Ther. 2010 Oct;32(11):1855-70. doi: 10.1016/j.clinthera.2010.10.011. Review.

PMID:
21095481
11.

Use of abatacept in rheumatoid arthritis.

von Kempis J, Dudler J, Hasler P, Kyburz D, Tyndall A, Zufferey P, Villiger PM.

Swiss Med Wkly. 2012 May 11;142:w13581. doi: 10.4414/smw.2012.13581. Review.

12.

Clinical response and tolerability to abatacept in patients with rheumatoid arthritis previously treated with infliximab or abatacept: open-label extension of the ATTEST Study.

Schiff M, Keiserman M, Codding C, Songcharoen S, Berman A, Nayiager S, Saldate C, Aranda R, Becker JC, Nys M, le Bars M, Reed DM, Poncet C, Dougados M.

Ann Rheum Dis. 2011 Nov;70(11):2003-7. doi: 10.1136/annrheumdis-2011-200316.

13.
14.

Selective costimulation modulation using abatacept in patients with active rheumatoid arthritis while receiving etanercept: a randomised clinical trial.

Weinblatt M, Schiff M, Goldman A, Kremer J, Luggen M, Li T, Chen D, Becker JC.

Ann Rheum Dis. 2007 Feb;66(2):228-34.

15.

Treatment of rheumatoid arthritis patients with abatacept and methotrexate significantly improved health-related quality of life.

Emery P, Kosinski M, Li T, Martin M, Williams GR, Becker JC, Blaisdell B, Ware JE Jr, Birbara C, Russell AS.

J Rheumatol. 2006 Apr;33(4):681-9.

PMID:
16568505
16.

Malignancies in the rheumatoid arthritis abatacept clinical development programme: an epidemiological assessment.

Simon TA, Smitten AL, Franklin J, Askling J, Lacaille D, Wolfe F, Hochberg MC, Qi K, Suissa S.

Ann Rheum Dis. 2009 Dec;68(12):1819-26. doi: 10.1136/ard.2008.097527.

17.

Role of abatacept in the management of rheumatoid arthritis.

Nogid A, Pham DQ.

Clin Ther. 2006 Nov;28(11):1764-78. Review.

PMID:
17212998
18.

Abatacept: a biologic immune modulator for rheumatoid arthritis.

Papagoras C, Drosos AA.

Expert Opin Biol Ther. 2011 Aug;11(8):1113-29. doi: 10.1517/14712598.2011.592825.

PMID:
21649536
20.

Abatacept improves both the physical and mental health of patients with rheumatoid arthritis who have inadequate response to methotrexate treatment.

Russell AS, Wallenstein GV, Li T, Martin MC, Maclean R, Blaisdell B, Gajria K, Cole JC, Becker JC, Emery P.

Ann Rheum Dis. 2007 Feb;66(2):189-94.

Supplemental Content

Support Center